by Michael F. MørupVanessa TaiebDamon WillemsMicah RoseNikos LyrisMark LamotteLaetitia GerlierHoward Thoma UCB Pharma, Copenhagen, Denmarkb UCB Pharma, Colombes, Francec UCB Pharma Brussels, Belgiumd UCB Pharma, Slough, UKe Th(is)2Modeling, Asse, Belgiumf IQVIA, Zaventem, Belgiumg University of Bristol, Bristol, UKh Clifton Insight, Bristol, UK

by Jeff ScheinMartin CloutierRebecca BungayMarjolaine Gauthier-LoiselleAnn Childressa Otsuka Pharmaceutical Development & Commercialization, Inc, Princeton, NJ, USAb Analysis Group, Inc., Montréal, Quebec, Canadac Center for Psychiatry and Behavioral Medicine, Las Vegas, NV, USA

by Meg FranklinMichael E. MinshallFederica PontenaniSunjay Devarajana Franklin Pharmaceutical Consulting, Cary, NC, USAb PRECISIONheor, Boston, MA, USAc Zambon USA Ltd, Cambridge, MA, USAd Zambon SpA, Bresso, Milano, Italye Department of Pulmonary/Critical Care Medicine, Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX, USA

by Karissa JohnstonLauren C. PowellEvan PopoffGil J. L’ItalienRobert Pawinski Aideen AhernSam LargeThang TranAaron Jenkinsa Broadstreet Health Economics and Outcomes Research, Vancouver, Canadab Biohaven Pharmaceuticals, New Haven, CT, USAc Pfizer Ltd, Tadworth, UKd Pfizer Canada, Kirkland, Canada

by Fiona StewartKristin KistlerYuxian DuRakesh R. SinghBonnie B. DeanSheldon X. Konga Cencora, Biopharma Services, Conshohocken, Pennsylvania, USAb Bayer HealthCare Pharmaceuticals, Whippany, New Jersey, USA

by Robert I. GriffithsAparna BhaveAlysha M. McGovernLiesl M. HargensCraig A. SolidAmit P. Amina Boston Scientific, Marlborough, MA, USAb Solid Research Group, LLC, St. Paul, MN, USAc Rush College of Medicine, Rush University Medical Center, Chicago, IL, USA

by Günter NiegischMarc-Oliver GrimmFraence HardtstockJulia KriegerAlexandra StarryUlrike OsowskiBarthold DeitersUlf MaywaldThomas WilkeMairead Kearneya Department of Urology, University Hospital and Medical Faculty of the Heinrich-Heine-University, Düsseldorf, Germanyb Center for Integrated Oncology, Aachen Bonn Cologne Düsseldorf, Germanyc Department of Urology, University Hospital Jena, Jena, Germanyd Cytel, Berlin, Germanye Merck Healthcare Germany GmbH, Weiterstadt, Germany, an affiliate of Merck KGaAf GWQ ServicePlus AG, Düsseldorf, Germanyg Drug Department, AOK PLUS, Dresden, Germanyh IPAM e.V., Wismar, Germanyi Merck Healthcare KGaA, Darmstadt, Germany

by Mark H. RozenbaumLiping HuangAlejandro CaneAdriano ArguedasRuth ChapmanDesmond Dillon-MurphyMaria J. TortVincenza SnowErica ChilsonRaymond Farkouha Pfizer Inc., Collegeville, PA, USAb Evidera, London, UK

by

by Wai Chee KuanKok Han CheeSazzli KasimKa Keat LimJuman Abdulelah DujailiKenneth Kwing-Chin LeeSiew Li Teoha School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, Selangor, Malaysiab Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysiac Department of Internal Medicine (Cardiology), Faculty of Medicine, Universiti Teknologi MARA (UITM), Jalan Hospital, Selangor, Malaysiad Cardiac Vascular and Lung Research Institute (CaVaLRI), Universiti Teknologi MARA (UITM), Jalan Hospital, Selangor, Malaysiae Department of Population Health Sciences, School of Life Course & Population Sciences, King’s College London, London, United Kingdomf Swansea University Medical School, Swansea University, Wales, United Kingdomg School of Pharmacy, Taylor’s University Malaysia, Subang Jaya, Selangor, Malaysia